This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Arellano C, Gandia P, Lafont T, Jongejan R, Chatelut E (2012) Determination of unbound fraction of imatinib and N-desmethyl imatinib, validation of an UPLCMS/MS assay and ultrafiltration method. J Chromatogr B Analyt Technol Biomed Life Sci 907:94-100. doi: 10.1016/j.jchromb.2012.09.007Search in Google Scholar
Bohnert T, Gan LS (2013) Plasma protein binding: from discovery to development. J Pharm Sci 102:2953-2994. doi: 10.1002/jps.23614Search in Google Scholar
Book WM (2002) Carvedilol: a nonselective beta blocking agent with antioxidant properties. Congest Heart Fail 8:173-177, 190. doi: 10.1111/j.1527-5299.2002.00718.xSearch in Google Scholar
Catalani S, Paganelli M, Gilberti ME, Rozzini L, Lanfranchi F, Padovani A, Apostoli P (2018) Free copper in serum: An analytical challenge and its possible applications. J Trace Elem Med Biol 45:176-180. doi: 10.1016/j.jtemb.2017.11.006Search in Google Scholar
Cibotaru D, Celestin MN, Kane MP, Musteata FM (2022) Comparison of liquid-liquid extraction, microextraction and ultrafiltration for measuring free concentrations of testosterone and phenytoin. Bioanalysis 14:195-204. doi: 10.4155/bio-2021-0249Search in Google Scholar
Dorn C, Kratzer A, Liebchen U, Schleibinger M, Murschhauser A, Schlossmann J, Kees F, Simon P, Kees MG (2018) Impact of Experimental Variables on the Protein Binding of Tigecycline in Human Plasma as Determined by Ultrafiltration. J Pharm Sci 107:739-744. doi: 10.1016/j.xphs.2017.09.006Search in Google Scholar
Downing K, Jensen BP, Grant S, Strother M, George P (2017) Quantification and clinical application of carboplatin in plasma ultrafiltrate. J Pharm Biomed Anal 138:373-377. doi: 10.1016/j.jpba.2017.01.045Search in Google Scholar
Du P, Han X, Li N, Wang H, Yang S, Song Y, Shi Y (2014) Development and validation of an ultrafiltration-UPLCMS/MS method for rapid quantification of unbound docetaxel in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci 967:28-35. doi: 10.1016/j.jchromb.2014.07.007Search in Google Scholar
Howard ML, Hill JJ, Galluppi GR, McLean MA (2010) Plasma protein binding in drug discovery and development. Comb Chem High Throughput Screen 13:170-187. doi: 10.2174/138620710790596745Search in Google Scholar
Imre S, Toma CM, Vari CE (2021) Evaluating the capacity of human serum albumin to reduce non-specific binding of meloxicam in the ultrafiltration process. Farmacia 69:1066-1072. doi:10.31925/farmacia.2021.6.7Search in Google Scholar
Jensen BP, Chin PK, Begg EJ (2011) Quantification of total and free concentrations of R- and S-warfarin in human plasma by ultrafiltration and LCMS/MS. Anal Bioanal Chem 401:2187-2193. doi: 10.1007/s00216-011-5303-xSearch in Google Scholar
Kratzer A, Kees F, Dorn C (2016) Unbound fraction of fluconazole and linezolid in human plasma as determined by ultrafiltration: Impact of membrane type. J Chromatogr B Analyt Technol Biomed Life Sci 1039:74-78. doi: 10.1016/j.jchromb.2016.10.040Search in Google Scholar
Kratzer A, Liebchen U, Schleibinger M, Kees MG, Kees F (2014) Determination of free vancomycin, ceftriaxone, cefazolin and ertapenem in plasma by ultrafiltration: impact of experimental conditions. J Chromatogr B Analyt Technol Biomed Life Sci 961:97-102. doi: 10.1016/j.jchromb.2014.05.021Search in Google Scholar
Larsen HS, Chin PK, Begg EJ, Jensen BP (2011) Quantification of total and unbound concentrations of lorazepam, oxazepam and temazepam in human plasma by ultrafiltration and LC-MS/MS. Bioanalysis 3:843-852. doi: 10.4155/bio.11.46Search in Google Scholar
Lee KJ, Mower R, Hollenbeck T, Castelo J, Johnson N, Gordon P, Sinko PJ, Holme K, Lee YH (2003) Modulation of nonspecific binding in ultrafiltration protein binding studies. Pharm Res 20:1015-1021. doi: 10.1023/a:1024406221962Search in Google Scholar
Morgan T (1994) Clinical pharmacokinetics and pharmacodynamics of carvedilol. Clin Pharmacokinet 26:335-346. doi: 10.2165/00003088-199426050-00002.Search in Google Scholar
Seyfinejad B, Ozkan SA, Jouyban A (2021) Recent advances in the determination of unbound concentration and plasma protein binding of drugs: Analytical methods. Talanta 225:122052. doi: 10.1016/j.talanta.2020.122052Search in Google Scholar
Taylor S, Harker A (2006) Modification of the ultrafiltration technique to overcome solubility and non-specific binding challenges associated with the measurement of plasma protein binding of corticosteroids. J Pharm Biomed Anal 41:299-303. doi: 10.1016/j.jpba.2005.10.031Search in Google Scholar
Toma CM, Imre S, Farczadi L, Ion V, Marc G (2023) Enantioselective binding of carvedilol to human serum albumin and alpha-1-acid glycoprotein. Chirality. doi: 10.1002/chir.23595.Search in Google Scholar
Toma CM, Imre S, Vari CE, Muntean DL, Tero-Vescan A (2021) Ultrafiltration method for plasma protein binding studies and its limitations. Processes 9:382. doi: 10.3390/pr9020382Search in Google Scholar
Vogeser M, Möhnle P, Briegel J (2007) Free serum cortisol: quantification applying equilibrium dialysis or ultrafiltration and an automated immunoassay system. Clin Chem Lab Med 45:521-525. doi: 10.1515/CCLM.2007.104Search in Google Scholar
Vuignier K, Schappler J, Veuthey JL, Carrupt PA, Martel S (2010) Drug-protein binding: a critical review of analytical tools. Anal Bioanal Chem 398:53-66. doi: 10.1007/s00216-010-3737-1Search in Google Scholar
Wang C, Williams NS (2013) A mass balance approach for calculation of recovery and binding enables the use of ultrafiltration as a rapid method for measurement of plasma protein binding for even highly lipophilic compounds. J Pharm Biomed Anal 75:112-117. doi: 10.1016/j.jpba.2012.11.018Search in Google Scholar
Yuan Y, Chang S, Zhang Z, Li Z, Li S, Xie P, Yau WP, Lin H, Cai W, Zhang Y, Xiang X (2020) A novel strategy for prediction of human plasma protein binding using machine learning techniques. Chemometr Intell Lab Syst 199: 103962. doi: 10.1016/j.chemolab.2020.103962Search in Google Scholar